logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Neeraj Agarwal

university of utah huntsman cancer institute
H指数:6
被引数:512

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG-1216 Phase 3 Trial

前列腺切除术后转移时间作为异时性mHSPC患者预后因素的评估：SWOG-1216 III期试验的二次分析

Prostate
IF2.5
2026-10-070
OAAI
Nicolas Sayegh; Yeonjung Jo; Umang Swami; Varun Nandakumar; Georges Gebrael; Zeynep Irem Ozay; Haoran Li; Krishnam Goel; Benjamin L. Maughan; Melissa Plets; Maha H. A. Hussain; Tanya B. Dorff; Primo N. Lara Jr.; Amir Goldkorn; Seth P. Lerner; Neeraj Agarwal
54 Primary Progressive Disease and Outcomes with First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Real-World IMDC Analysis

54 转移性肾细胞癌中一线纳武利尤单抗联合伊匹木单抗治疗的原发进展性疾病与结局：一项真实世界IMDC分析

Oncologist
IF4.2
2026-09-020
OAAI
Elio Ibrahim; Wanling Xie; Razane El Hajj Chehade; Neeraj Agarwal; Liliana Ascione; Parker Baumgarten; Tarek Baroud; Pablo Barios; Benoit Beuselinck; Christian Camil; Sarah El Sarout; Marc eid; Jad El Masri; Ali Hajj Ali; Christian Kollmannsberger; Suzanna Lee; Jae Lyun Lee; Marc Machaalani; Gaelle Nafeh; Rashad Nawfal; Heber Reyes Garcia; Mustafa Saleh; Connor Wells; Lori Wood; Jessica Voce; Sylvan Baca; Daniel Heng; Toni Choueiri; Rana McKay
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study

免疫检查点抑制剂再挑战在转移性透明细胞肾细胞癌中的结局：全球真实世界证据研究的结果

ESMO Open
IF8.3
2026-04-210
OAAI
A. Cigliola; B.A. Maiorano; F. Rossari; V. Tateo; C. Mercinelli; N. Dizman; M. Colecchia; F. De Cobelli; A. Larcher; G. Rosiello; A. Briganti; F. Montorsi; U. Capitanio; P.E. Spiess; N. Agarwal; S.K. Pal; A. Necchi
Homologous recombination deficiency and genomic alterations in advanced prostate cancer: insights for precision therapy

同源重组缺陷和基因组改变在晚期前列腺癌中的研究：精准治疗的启示

Oncologist
IF4.2
2026-04-010
PRE
Mercinelli, Chiara; Pavlick, Dean; Agarwal, Neeraj; Spiess, Philippe E.; Li, Roger; Kamat, Ashish M.; Grivas, Petros; Gupta, Shilpa; Maiorano, Brigida Anna; Tateo, Valentina; Cigliola, Antonio; Piacentini, Michela; Jacob, Joseph M.; Bratslavsky, Gennady; Basnet, Alina; Ross, Jeffrey S.; Necchi, Andrea
Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials

种族与接受阿帕鲁他胺治疗患者生存期的关联：两项III期试验的合并分析

Cancer
IF5.1
2026-01-010
PRE
Gebrael, Georges; Agarwal, Neeraj; Morgans, Alicia K.; Vince, Randy; Swami, Umang; Jia, Angela Y.; Zaorsky, Nicholas; Chehade, Chadi Hage; Ozay, Zeynep Irem; Malone, Shawn; Morgan, Scott C.; Wallis, Christopher J. D.; Kishan, Amar U.; Barata, Pedro C.; Chowdhury, Simon; Garcia, Jorge A.; Sheng, Iris; Brown, Jason R.; Small, Eric J.; Sun, Yilun; Shore, Neal D.; Saad, Fred; Spratt, Daniel E.; Roy, Soumyajit
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

早期对转移性激素敏感型前列腺癌的 prostate-specific antigen (PSA) 阳性反应预测

Nature Communications
IF15.7
2025-12-170
OAAI
Soumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer

FOLH1 (PSMA) RNA在原发性和转移性前列腺癌中高表达的分 子与临床相关性

The Oncologist
IF0
2025-11-110
OA
Rana R McKay, MD; Shayan S Nazari, PhD; Andrew Elliott, PhD; Jennifer R Ribeiro, PhD; Brent S Rose, MD; Pedro C Barata, MD, MSc; Deepak Kilari, MD; Rohan Garje, MD; Neeraj Agarwal, MD; Norm Smith, MD; Emmanuel S Antonarakis, MD; Aditya Bagrodia, MD; Himisha Beltran, MD
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial

Niraparib和abiraterone acetate联合prednisone治疗HRR缺陷型转移性去势敏感前列腺癌：一项随机III期试验

Nature Medicine
IF50
2025-10-070
OAAI
Gerhardt Attard; Neeraj Agarwal; Julie N. Graff; Shahneen Sandhu; Eleni Efstathiou; Mustafa Özgüroğlu; Andrea J. Pereira de Santana Gomes; Karina Vianna; Hong Luo; Geoffrey T. Gotto; Heather H. Cheng; Won Kim; Carly R. Varela; Daneen Schaeffer; Kassie Kramer; Susan Li; Benoit Baron; Fei Shen; Suneel D. Mundle; Sharon A. McCarthy; David Olmos; Kim N. Chi; Dana E. Rathkopf
Characterizing carbonic anhydrase 9 and HIF-2α RNA expression in clear cell renal cell carcinoma (ccRCC)

表征碳酸酐酶9和HIF-2α RNA在透明细胞肾细胞癌(ccRCC)中的表达

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Chen, Yu-Wei; Nazari, Shayan; Elliott, Andrew; Kulkami, Ninad; Smith, Norm; Nawfal, Rashad; Barata, Pedro C.; Bagrodia, Aditya; Rose, Brent; McDermott, David; Signoretti, Sabina; Machaalani, Marc; Shiva, Shankar; Hofman, Michael; Agarwal, Neeraj; Pal, Sumanta; Choueri, Toni; Mckay, Rana
A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapy

TROPHY-U-01研究（队列2）的通俗总结：在无法接受顺铂为基础化疗的转移性尿路上皮癌患者中，免疫疗法后使用sacituzumab govitecan的疗效。

FUTURE ONCOLOGY
IF2.6
2025-09-010
OAAI
Grivas, Petros; Tagawa, Gurdeep; Jain, Rohit K.; Bupathi, Manojkumar; Balar, Arjun; Rezazadeh Kalebasty, Arash; George, Saby; Palmbos, Phillip; Nordquist, Luke; Petrylak, Daniel P.; Davis, Nancy; Sternberg, Cora N.; Agarwal, Neeraj; Park, Chandler; Tonelli, Julia; Zhou, Huafeng; Bangs, Rick; Loriot, Yohann
IUC24428-85 Real-world effectiveness of ipilimumab plus nivolumab in second-line in patients with metastatic clear cell renal cell carcinoma (mccRCC) based on prior receipt of PD-1/L1 inhibitors

IUC24428-85 基于既往接受PD-1/L1抑制剂治疗的患者，伊匹木单抗联合纳武利尤单抗在二线治疗转移性透明细胞肾细胞癌（mccRCC）中的真实世界有效性

The Oncologist
IF0
2025-08-290
OA
Z I Ozay; Y Jo; G Gebrael; M Ostrowski; E Murdock; S Jamie-Casas; M Zugman; N Agarwal; S Pal; U Swami

研究方向

暂未获取到该数据
U
Umang Swami
H 指数:27论文数:417被引数:3,148
B
Benjamin L. Maughan
H 指数:29论文数:393被引数:3,284
S
Sumanta K. Pal
H 指数:88论文数:1,402被引数:3.4万
T
Toni K. Choueiri
H 指数:149论文数:2,479被引数:12.6万
G
Georges Gebrael
H 指数:10论文数:146被引数:461
N
Nicolas Sayegh
H 指数:17论文数:199被引数:1,857
N
Neal D. Shore
H 指数:84论文数:1,298被引数:4.5万
F
Fred Saad
H 指数:127论文数:1,911被引数:10.7万
P
Petros Grivas
H 指数:61论文数:916被引数:2.4万
R
Roberto Nussenzveig
H 指数:28论文数:203被引数:3,029